bupropion has been researched along with Briquet Syndrome in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papakostas, GI | 1 |
| Stahl, SM | 1 |
| Krishen, A | 1 |
| Seifert, CA | 1 |
| Tucker, VL | 1 |
| Goodale, EP | 1 |
| Fava, M | 1 |
| Davidson, J | 1 |
| Pelton, S | 1 |
1 review available for bupropion and Briquet Syndrome
| Article | Year |
|---|---|
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
Topics: Anxiety Disorders; Bupropion; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Double-Blind M | 2008 |
1 trial available for bupropion and Briquet Syndrome
| Article | Year |
|---|---|
Forms of atypical depression and their response to antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bupropion; Clinical Trial | 1986 |